Table 5.
Multiple Cox regressions for post-relapse survival
Hazard ratio (95% CI) | p-value | |
---|---|---|
Randomized treatment: XELOX or FOLFOX vs leucovorin and fluorouracil | 0·92 (0·81–1·05) | 0·23 |
Sex (women vs men) | 1·02 (0·90–1·16) | 0·71 |
Age (<70 years vs ≥70 years) | 0·70 (0·60–0·81) | <0·0001 |
T stage (T1–2 vs T3–4) | 0·82 (0·61–1·10) | 0·19 |
N stage (N1 vs N2) | 0·73 (0·64–0·83) | <0·0001 |
XELOX=capecitabine plus oxaliplatin. FOLFOX=leucovorin and fluorouracil plus oxaliplatin. T stage=tumour stage. N stage=nodal stage.